April Apfelbaum, PhD

Beloit College Alum🥎, Go blue 〽️, currently a postdoctoral fellow at Dana Farber Cancer Institute 🧬🦠, crocheted a blanket of the periodic table for fun🧶

[April Apfelbaum, PhD @ApfelbaumApril]

@erikrpeterson92 @DanWahlMD @castro2355_mg Congrats!!!

[April Apfelbaum, PhD @ApfelbaumApril]

@TyMillerLab @BrainTumourOrg @caseccc Congrats!!!

[April Apfelbaum, PhD @ApfelbaumApril]

@DrEndersby Thank you!!

[April Apfelbaum, PhD @ApfelbaumApril]

Really proud of this work and our team’s effort to help gain insights into these rare pediatric brain tumors 🧬

[April Apfelbaum, PhD @ApfelbaumApril]

@MonicaPomaville Thank you!

[April Apfelbaum, PhD @ApfelbaumApril]

@castro2355_mg Thank you Maria!

[April Apfelbaum, PhD @ApfelbaumApril]

@jstraehlaMD @seattlechildren @UW_Pediatrics @UWBioE @fredhutch So happy for you!!!!

[April Apfelbaum, PhD @ApfelbaumApril]

@VitanzaNick @NeuroOnc @seattlechildren Great talk Nick!!

[April Apfelbaum, PhD @ApfelbaumApril]

@myron_evansPhD @EvansBrainLab @kate_amato @pbtrfseattle @UnravelCancer @NCICancerBio Woohoo!!!🎉

[April Apfelbaum, PhD @ApfelbaumApril]

@VitanzaNick 😂😂😂😂 congrats king 👑

[AACR @AACR]

Today, the @US_FDA granted accelerated approval to the RAF inhibitor tovorafenib for patients 6 months and older with relapsed or refractory pediatric low-grade glioma with certain BRAF alterations. Learn more: https://t.co/e1dhCjmoe4

[April Apfelbaum, PhD @ApfelbaumApril]

@Lawlorlab @CUREchildcancer @seattlechildren @foundation_sam Superstars!!! 😍😍😍

[April Apfelbaum, PhD @ApfelbaumApril]

@VitanzaNick @Atleti @MattDun17 @pumorister Aww so fun!!

[April Apfelbaum, PhD @ApfelbaumApril]

@sydneytMSTP @DamonRunyon Thank you! Miss you!

[April Apfelbaum, PhD @ApfelbaumApril]

@heide_ford @DamonRunyon Thank you!! Hope all is well with you!

[April Apfelbaum, PhD @ApfelbaumApril]

@OSaulnier_ @DamonRunyon Thank you!!

[April Apfelbaum, PhD @ApfelbaumApril]

@MaggieChasse Aww thank you 😍😍

[April Apfelbaum, PhD @ApfelbaumApril]

@Lawlorlab Thank you!!! Couldn’t have gotten here without your training! ❤️

[Damon Runyon Cancer Research Foundation @DamonRunyon]

Congratulations to the first class of Damon Runyon-@StJudeResearch Pediatric Cancer Fellows! These exceptional early-career scientists are working to accelerate progress and develop cures for some of the most difficult-to-treat cancers affecting children: https://t.co/Pn5ghAsDWO

[April Apfelbaum, PhD @ApfelbaumApril]

@NotScheck @WhatTheScheck Quality choices